25% Fewer Birth Control Pills: How Medicaid Cut Walloped Planned Parenthood Services

The human and organizational toll has been severe. According to Planned Parenthood, its affiliates closed nearly 30 of the roughly 600 clinics nationwide during the defunding period, directly attributing these closures to the funding loss. Service delivery plummeted: birth control pill distribution dropped by approximately 25%, and breast cancer screenings fell by around 20% compared to the prior year. Many patients—particularly in underserved areas where Planned Parenthood often serves as the primary source of reproductive healthcare—likely went without care entirely. The impact was not uniform; affiliates in different states scrambled to maintain services under varying legal and financial constraints. Planned Parenthood of Wisconsin halted abortions for about a month and voluntarily surrendered its “essential community provider” designation to sidestep the funding ban and resume Medicaid reimbursement. In Arizona, the local affiliate paused many of its services for Medicaid patients, leaving a gap in the safety net. The two smaller regional providers, also swept into the defunding dragnet, faced similar disruptions, though less publicly documented.

The restoration of Medicaid funding does not signal an end to the legal and regulatory turbulence surrounding reproductive healthcare. The defunding episode exposed the fragility of abortion providers’ financial models in a era of heightened political scrutiny. Since the 2022 Supreme Court decision in Dobbs v. Jackson Women’s Health Organization overturned Roe v. Wade, states have erected a patchwork of abortion bans and restrictions, driving clinic closures even in jurisdictions where abortion remains legal. The 2025 defunding law added a federal layer, weaponizing Medicaid—a cornerstone of low-income healthcare access—to squeeze providers that also offer abortion. While the current resumption (the exact administrative mechanism remains unclear) restores cash flow, it is likely a temporary reprieve in a larger ideological war. Future legislative sessions could reintroduce similar or harsher provisions, and the legal community will watch closely for constitutional challenges under the Spending Clause and the Hyde Amendment’s progeny. Meanwhile, providers face the daunting task of rebuilding networks, rehiring staff, and regaining patient trust after a year of uncertainty. Some closures are permanent, leaving geographic and demographic holes in the reproductive healthcare map that will take years to fill, if ever. For the millions of low-income Americans who rely on Medicaid for contraception, cancer screenings, and sexually transmitted infection testing, the resumption brings relief—but the memory of a year spent without accessible care will linger, a stark reminder of how quickly politically motivated budget maneuvers can destabilize essential health services.